Building Companies

The OBIO® Capital Access Advisory Program (CAAP®) operates downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. OBIO’s CAAP® creates high value deal flow for both companies and investors, and opportunity to participate at the OBIO® Investment Summit and other international investment conferences.

What is OBIO’s CAAP®?

  • A competitive, 9-12 month structured program for health science companies starting to raise a post-seed financing round over the next 12-18 months.

  • CAAP® covers three fundamental business themes:

    • Business strategic planning & increasing the ROI for investors

    • Advanced fundraising strategies

    • Closing an investment round and business development contract

Benefits for CAAP® companies:

  • Strategic Connections: Receive warm introductions and strategic guidance to venture investors, healthcare executives and business experts customized to your business strategy

  • Lead Generation: Leverage support from the OBIO® team to reach out to VCs and strategic partners at international conferences to generate new leads

  • Valuable Network Access: Get connected with the CAAP® and EAHN® alumni network of founders, as well as executive teams from OBIO® companies that have successfully closed financing

  • Continuous Support: Enjoy ongoing support throughout your company’s journey, become a CAAP® alumnus

Eligibility requirements:

  • Be a private, high-potential bioscience company based in Ontario

  • Focus on developing human health science products including but not limited to: therapeutics, medical devices, diagnostics or digital health technologies

  • Starting to raise a post-seed financing round in the next 12-18 months

  • Have enough resources and funding runway to reach key value inflection points

  • Chief Executive Officer and/or other members of the senior management team of each company admitted into the program must be actively engaged in the program. This includes participation in CAAP® specific workshops and other events throughout the CAAP® term

CAAP® culminates with a presentation at the OBIO® Investment Summit (OIS):

• Present to and meet with global health sciences investors & strategics

• > $3B raised by Summit companies since 2018

• 275+ companies have presented at the Summit

*We are not currently accepting applications*

Have a question? Contact us:

Parnian Tajbakhsh
Senior Manager, Capital Access
parniantajbakhsh@obio.ca


CAAP® Companies 2024-2025

CAAP® Companies 2023

CAAP® Companies 2022

CAAP® Companies 2021

CAAP® Companies 2020

CAAP® Companies 2019

FUNDED BY THE GOVERNMENT OF CANADA.